-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Immix Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2021 to Q1 2024.
- Immix Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$302K.
- Immix Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$52.1K.